A 2-year study by Tel Aviv University researchers is being hailed as a test for vaccines and also to give early warning of a potential pandemic. Smartwatch sensors from Israel’s Biobeat (see here previously) monitored the heart, lungs, blood oxygen, … Continue reading →

Israel’s BioBeat (see here previously) is integrating its wearable devices for remote patient monitoring into the Current Health home care platform offered by Best Buy Health in the US.  The devices monitor 13 parameters, e.g., blood pressure, blood oxygen levels, … Continue reading →

Israel’s BioBeat (see here previously) has just completed a study of its wearable chest monitor in use on 521 patients. It reported a 77% success rate for detecting those at high risk of deterioration. This compared with 20% monitored using … Continue reading →

Israel’s Sheba Medical Center has just completed a clinical study of patients using the wearable vital signs monitor from Israel’s BioBeat (see here previously). It shows that the telehealth device can detect patient deterioration 38 hours before clinical deterioration, in … Continue reading →

Tel Aviv University researchers used smart sensors from Israel’s BioBeat to measure physiological reactions of 160 subjects to the second dose of the Pfizer vaccine. They showed that side effects increased over a 48-hour period, often contradicting reports of the … Continue reading →

Europe’s CE Mark has been awarded to the Remote Patient AI Monitoring Platform developed by Israel’s Biobeat Medical. The system has recently been radically upgraded (see previous) and now automatically and continuously tracks 15 cardio-pulmonary vital signs. https://www.prnewswire.co.uk/news-releases/biobeat-s-ai-powered-remote-patient-monitoring-platform-receives-a-full-ce-mark-883148022.html https://www.bio-beat.com/

Israel’s 2019 Genesis Prize winner, Natan Sharansky, donated his $1 million prize to 10 Israeli startups developing innovations to combat Covid-19. The 10 are Kamada, Pluristem, Sight Diagnostics, Sonovia, Biobeat, EyeControl, K Health, Picodya, IAI and MyZeppi. https://nocamels.com/2020/12/sharansky-genesis-prize-10-companies-covid/ https://www.genesisprize.org/press-center/2020-12-24-genesis-prize-and-start-up-nation-central-announce-winners-of-the-competition-in-honor-of-natan-sharansky

In Sep 2019 Israel’s Biobeat received FDA approval for its medical smartwatch and patch (see here). It has now also received CE Mark approval. The smartwatch measures blood pressure, cardiac output, stroke volume, blood oxygenation and heart rate. https://www.medgadget.com/2020/03/biobeat-receives-eu-clearance-for-vital-sign-monitoring-with-wristwatch-and-patch.html

Israel’s Biobeat develops wireless products (wristwatch and patch) to measure blood pressure, oxygenation, pulse, stroke volume and more. Both items sync data to the cloud, enabling remote monitoring. The US FDA has just given clearance to the combined products. https://www.calcalistech.com/ctech/articles/0,7340,L-3769057,00.html … Continue reading →